Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

NLRP1 promotes tumor growth by enhancing inflammasome activation and suppressing apoptosis in metastatic melanoma

Oncogene volume 36, pages 3820–3830 (2017)Cite this article

Subjects

Abstract

Inflammasomes are mediators of inflammation, and constitutively activated NLRP3 inflammasomes have been linked to interleukin-1β (IL-1β)-mediated tumorigenesis in human melanoma. Whereas NLRP3 regulation of caspase-1 activation requires the adaptor protein ASC (apoptosis-associated speck-like protein containing a CARD (caspase recruitment domain)), caspase-1 activation by another danger-signaling sensor NLRP1 does not require ASC because NLRP1 contains a C-terminal CARD domain that facilitates direct caspase-1 activation via CARD–CARD interaction. We hypothesized that NLRP1 has additional biological activities besides IL-1β maturation and investigated its role in melanoma tumorigenesis. NLRP1 expression in melanoma was confirmed by analysis of 216 melanoma tumors and 13 human melanoma cell lines. Unlike monocytic THP-1 cells with prominent nuclear localization of NLRP1, melanoma cells expressed NLRP1 mainly in the cytoplasm. Knocking down NLRP1 revealed a tumor-promoting property of NLRP1 both in vitro and in vivo. Mechanistic studies showed that caspase-1 activity, IL-1β production, IL-1β secretion and nuclear factor-kB activity were reduced by knocking down of NLRP1 in human metastatic melanoma cell lines 1205Lu and HS294T, indicating that NLRP1 inflammasomes are active in metastatic melanoma. However, unlike previous reports showing that NLRP1 enhances pyroptosis in macrophages, NLRP1 in melanoma behaved differently in the context of cell death. Knocking down NLRP1 increased caspase-2, -9 and -3/7 activities and promoted apoptosis in human melanoma cells. Immunoprecipitation revealed interaction of NLRP1 with CARD-containing caspase-2 and -9, whereas NLRP3 lacking a CARD motif did not interact with the caspases. Consistent with these findings, NLRP1 activation but not NLRP3 activation reduced caspase-2, -9 and -3/7 activities and provided protection against apoptosis in human melanoma cells, suggesting a suppressive role of NLRP1 in caspase-3/7 activation and apoptosis via interaction with caspase-2 and -9. In summary, we showed that NLRP1 promotes melanoma growth by enhancing inflammasome activation and suppressing apoptotic pathways. Our study demonstrates a tumor-promoting role of NLRP1 in cancer cells.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

References

  1. Diakos CI, Charles KA, McMillan DC, Clarke SJ . Cancer-related inflammation and treatment effectiveness. Lancet Oncol 2014; 15: e493–e503.

    Article  PubMed  Google Scholar 

  2. Solinas G, Marchesi F, Garlanda C, Mantovani A, Allavena P . Inflammation-mediated promotion of invasion and metastasis. Cancer Metastasis Rev 2010; 29: 243–248.

    Article  CAS  PubMed  Google Scholar 

  3. Multhoff G, Molls M, Radons J . Chronic inflammation in cancer development. Front Immunol 2012; 2: 98.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Watari K, Shibata T, Kawahara A, Sata K, Nabeshima H, Shinoda A et al. Tumor-derived interleukin-1 promotes lymphangiogenesis and lymph node metastasis through M2-type macrophages. PLoS ONE 2014; 9: e99568.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Song X, Krelin Y, Dvorkin T, Bjorkdahl O, Segal S, Dinarello CA et al. CD11b+/Gr-1+ immature myeloid cells mediate suppression of T cells in mice bearing tumors of IL-1beta-secreting cells. J Immunol 2005; 175: 8200–8208.

    Article  CAS  PubMed  Google Scholar 

  6. Voronov E, Shouval DS, Krelin Y, Cagnano E, Benharroch D, Iwakura Y et al. IL-1 is required for tumor invasiveness and angiogenesis. Proc Natl Acad Sci USA 2003; 100: 2645–2650.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Dunn JH, Ellis LZ, Fujita M . Inflammasomes as molecular mediators of inflammation and cancer: potential role in melanoma. Cancer Lett 2012; 314: 24–33.

    Article  CAS  PubMed  Google Scholar 

  8. Okamoto M, Liu W, Luo Y, Tanaka A, Cai X, Norris DA et al. Constitutively active inflammasome in human melanoma cells mediating autoinflammation via caspase-1 processing and secretion of interleukin-1beta. J Biol Chem 2010; 285: 6477–6488.

    Article  CAS  PubMed  Google Scholar 

  9. Davis BK, Wen H, Ting JP . The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu Rev Immunol 2011; 29: 707–735.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Kolb R, Liu GH, Janowski AM, Sutterwala FS, Zhang W . Inflammasomes in cancer: a double-edged sword. Protein Cell 2014; 5: 12–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Liu W, Luo Y, Dunn JH, Norris DA, Dinarello CA, Fujita M . Dual role of apoptosis-associated speck-like protein containing a CARD (ASC) in tumorigenesis of human melanoma. J Invest Dermatol 2013; 133: 518–527.

    Article  CAS  PubMed  Google Scholar 

  12. Faustin B, Lartigue L, Bruey JM, Luciano F, Sergienko E, Bailly-Maitre B et al. Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation. Mol Cell 2007; 25: 713–724.

    Article  CAS  PubMed  Google Scholar 

  13. Hofmann K, Bucher P, Tschopp J . The CARD domain: a new apoptotic signalling motif. Trends Biochem Sci 1997; 22: 155–156.

    Article  CAS  PubMed  Google Scholar 

  14. Bouchier-Hayes L, Martin SJ . CARD games in apoptosis and immunity. EMBO Rep 2002; 3: 616–621.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Chu ZL, Pio F, Xie Z, Welsh K, Krajewska M, Krajewski S et al. A novel enhancer of the Apaf1 apoptosome involved in cytochrome c-dependent caspase activation and apoptosis. J Biol Chem 2001; 276: 9239–9245.

    Article  CAS  PubMed  Google Scholar 

  16. Kummer JA, Broekhuizen R, Everett H, Agostini L, Kuijk L, Martinon F et al. Inflammasome components NALP 1 and 3 show distinct but separate expression profiles in human tissues suggesting a site-specific role in the inflammatory response. J Histochem Cytochem 2007; 55: 443–452.

    Article  CAS  PubMed  Google Scholar 

  17. Zhong FL, Mamaï O, Sborgi L, Boussofara L, Hopkins R, Robinson K et al. Germline NLRP1 Mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation. Cell 2016; 167: 187–202.

    Article  CAS  PubMed  Google Scholar 

  18. Raskin L, Fullen DR, Giordano TJ, Thomas DG, Frohm ML, Cha KB et al. Transcriptome profiling identifies HMGA2 as a biomarker of melanoma progression and prognosis. J Invest Dermatol 2013; 133: 2585–2592.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Riker AI, Enkemann SA, Fodstad O, Liu S, Ren S, Morris C et al. The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis. BMC Med Genomics 2008; 1: 13.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Kabbarah O, Nogueira C, Feng B, Nazarian RM, Bosenberg M, Wu M et al. Integrative genome comparison of primary and metastatic melanomas. PLoS ONE 2010; 5: e10770.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Chanput W, Mes JJ, Wichers HJ . THP-1 cell line: an in vitro cell model for immune modulation approach. Int Immunopharmacol 2014; 23: 37–45.

    Article  CAS  PubMed  Google Scholar 

  22. Martinon F, Burns K, Tschopp J . The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 2002; 10: 417–426.

    Article  CAS  PubMed  Google Scholar 

  23. Datta-Mitra A, Kundu-Raychaudhuri S, Mitra A, Raychaudhuri SP . Cross talk between neuroregulatory molecule and monocyte: nerve growth factor activates the inflammasome. PLoS ONE 2015; 10: e0121626.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Bruey JM, Bruey-Sedano N, Luciano F, Zhai D, Balpai R, Xu C et al. Bcl-2 and Bcl-XL regulate proinflammatory caspase-1 activation by interaction with NALP1. Cell 2007; 129: 45–56.

    Article  CAS  PubMed  Google Scholar 

  25. Levinsohn JL, Newman ZL, Hellmich KA, Fattah R, Getz MA, Liu S et al. Anthrax lethal factor cleavage of Nlrp1 is required for activation of the inflammasome. PLoS Pathog 2012; 8: e1002638.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Kodiha M, Bański P, Stochaj U . Computer-based fluorescence quantification: a novel approach to study nucleolar biology. BMC Cell Biol 2011; 12: 25.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Bani MR, Rak J, Adachi D, Wiltshire R, Trent JM, Kerbel RS et al. Multiple features of advanced melanoma recapitulated in tumorigenic variants of early stage (radial growth phase) human melanoma cell lines: evidence for a dominant phenotype. Cancer Res 1996; 56: 3075–3086.

    CAS  PubMed  Google Scholar 

  28. Chow MT, Sceneay J, Paget C, Wong CS, Duret H, Tschopp J et al. NLRP3 suppresses NK cell-mediated responses to carcinogen-induced tumors and metastases. Cancer Res 2012; 72: 5721–5732.

    Article  CAS  PubMed  Google Scholar 

  29. Ahmad I, Muneer KM, Tamimi IA, Chang ME, Ata MO, Yusuf N . Thymoquinone suppresses metastasis of melanoma cells by inhibition of NLRP3 inflammasome. Toxicol Appl Pharmacol 2013; 270: 70–76.

    Article  CAS  PubMed  Google Scholar 

  30. Tarassishin L, Casper D, Lee SC . Aberrant expression of interleukin-1β and inflammasome activation in human malignant gliomas. PLoS ONE 2014; 9: e103432.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Kumar S . Caspase 2 in apoptosis, the DNA damage response and tumor suppression: enigma no more? Nat Rev Cancer 2009; 9: 897–903.

    Article  CAS  PubMed  Google Scholar 

  32. Labbe K, Saleh M Pyroptosis: a caspase-1-dependent programmed cell death and a barrier to infection. In: Couillin I, Pétrilli V, Martinon F (eds). The Inflammasomes, Progress in Inflammation Research. Springer Basel AG: Switzerland, 2011, pp 17–36.

    Google Scholar 

  33. Newman ZL, Printz MP, Liu S, Crown D, Breen L, Miller-Randolph S et al. Susceptibility to anthrax lethal toxin-induced rat death is controlled by a single chromosome 10 locus that includes rNlrp1. PLoS Pathog 2010; 6: e1000906.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Brennan MA, Cookson BT . Salmonella induces macrophage death by caspase-1-dependent necrosis. Mol Microbiol 2000; 38: 31–40.

    Article  CAS  PubMed  Google Scholar 

  35. Cervantes J, Nagata T, Uchijima M, Shibata K, Koide Y . Intracytosolic Listeria monocytogenes induces cell death through caspase-1 activation in murine macrophages. Cell Microbiol 2008; 10: 41–52.

    CAS  PubMed  Google Scholar 

  36. Rayamajhi M, Zhang Y, Miao EA . Detection of pyroptosis by measuring released lactate dehydrogenase activity. Methods Mol Biol 2013; 1040: 85–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Chavarría-Smith J, Vance RE . The NLRP1 inflammasomes. Immunol Rev 2015; 265: 22–34.

    Article  PubMed  Google Scholar 

  38. Frederick Lo C, Ning X, Gonzales C, Ozenberger BA . Induced expression of death domain genes NALP1 and NALP5 following neuronal injury. Biochem Biophys Res Commun 2008; 366: 664–669.

    Article  CAS  PubMed  Google Scholar 

  39. Modlin IM, Kidd M, Latich I, Zikusoka MN, Eick GN, Mane SM et al. Genetic differentiation of appendiceal tumor malignancy: a guide for the perplexed. Ann Surg 2006; 244: 52–60.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Meng XF, Wang XL, Tian XJ, Yang ZH, Chu GP, Zhang J et al. Nod-like receptor protein 1 inflammasome mediates neuron injury under high glucose. Mol Neurobiol 2014; 49: 673–684.

    Article  CAS  PubMed  Google Scholar 

  41. Kent A, Blander JM . Nod-like receptors: key molecular switches in the conundrum of cancer. Front Immunol 2014; 5: 185.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Trask DK, Muller MT . Stabilization of type I topoisomerase-DNA covalent complexes by actinomycin D. Proc Natl Acad Sci USA 1988; 85: 1417–1421.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Pommier Y, Leo E, Zhang H, Marchand C . DNA topoisomerases and their poisoning by anticancer and antibacterial drugs. Chem Biol 2010; 17: 421–433.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Baptiste-Okoh N, Barsotti AM, Prives C . A role for caspase 2 and PIDD in the process of p53-mediated apoptosis. Proc Natl Acad Sci USA 2008; 105: 1937–1942.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Caporali S, Levati L, Graziani G, Muzi A, Atzori MG, Bonmassar E et al. NF-κB is activated in response to temozolomide in an AKT-dependent manner and confers protection against the growth suppressive effect of the drug. J Transl Med 2012; 10: 252.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank the University of Colorado Cancer Center (UCCC) Support Grant (P30CA046934), the Skin Diseases Research Cores Grant (P30AR057212), the Flow Cytometry Core (Christine Childs and Karen Helm) for helping with FACS, and Dr Archana Gopalan (University of Colorado Anschutz Medical Campus) for helping with animal experiments. Imaging experiments were performed in the University of Colorado Anschutz Medical Campus Advance Light Microscopy Core (Radu Moldovan) supported in part by NIH/NCATS Colorado CTSI Grant Number UL1 TR001082. ZZ and JMS are recipients of a training grant, 5T32AR007411-32. This work was supported, in whole or in part, by Veterans Affairs Merit Review Award 5I01BX001228 (to MF), NIH/NCI R01CA197919 (to MF), Cancer League of Colorado (to MF) and NIH/NIAMS 2R01AR045584 (to RAS and MF).

Author information

Authors and Affiliations

  1. Department of Dermatology, University of Colorado Denver SOM, CO, Aurora, USA

    Z Zhai, W Liu, M Kaur, Y Luo, J Domenico, J M Samson, Y G Shellman, D A Norris & M Fujita

  2. Denver Veterans Affairs Medical Center, CO, Denver, USA

    D A Norris & M Fujita

  3. Department of Medicine, University of Colorado Denver SOM, Aurora, CO, USA

    C A Dinarello

  4. Human Medical Genetics and Genomics Program, University of Colorado Denver SOM, CO, Aurora, USA

    R A Spritz

Authors
  1. Z Zhai
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M Kaur
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Y Luo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J Domenico
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J M Samson
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Y G Shellman
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. D A Norris
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. C A Dinarello
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. R A Spritz
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. M Fujita
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M Fujita.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies this paper on the Oncogene website

Supplementary information

Rights and permissions

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhai, Z., Liu, W., Kaur, M. et al. NLRP1 promotes tumor growth by enhancing inflammasome activation and suppressing apoptosis in metastatic melanoma. Oncogene 36, 3820–3830 (2017). https://doi.org/10.1038/onc.2017.26

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/onc.2017.26

This article is cited by

Search

Advanced search

Quick links